Hebert Jeffrey R, Manago Mark M
Int J MS Care. 2017 May-Jun;19(3):151-157. doi: 10.7224/1537-2073.2016-027.
People with multiple sclerosis (MS) frequently have impaired postural control (balance). Psychometric properties of clinical tests of balance for individuals with MS, including the computerized dynamic posturography sensory organization test (CDP-SOT), are poorly understood. This study aimed to determine the reliability and discriminant validity of the CDP-SOT in people with MS.
The CDP-SOT was performed on 30 participants with MS. A 2-week-interval, repeated-measures (sessions 1 and 2) design was implemented to investigate test-retest reliability of the CDP-SOT and the ability of the CDP-SOT to discriminate between participants with lower versus higher disability. Self-reported disability level was based on Patient-Determined Disease Steps (PDDS) scale scores: lower (PDDS scale score, 0-3; n = 17) and higher (PDDS scale score, 4-6; n = 13).
All six conditions of the CDP-SOT had good-to-excellent reliability (interclass correlation coefficients, 0.70-0.90) and excellent reliability for composite scores (0.90). Composite scores were significantly greater in the lower-disability group versus the higher-disability group at session 1 (70.89 vs. 48.60, P = .001) and session 2 (74.82 vs. 48.85, P = .002).
The CDP-SOT is a reliable measure of balance and accurately differentiates disability status in people with MS. Collectively, the results support clinical application of the CDP-SOT as a reliable and valid measure of disease-related progression of impaired balance related to sensory integration and its utility in determining changes in balance in response to treatment.
多发性硬化症(MS)患者经常存在姿势控制(平衡)受损的情况。对于MS患者平衡功能临床测试的心理测量特性,包括计算机化动态姿势描记术感觉组织测试(CDP-SOT),人们了解甚少。本研究旨在确定CDP-SOT在MS患者中的可靠性和区分效度。
对30名MS患者进行CDP-SOT测试。采用间隔2周的重复测量(第1次和第2次测试)设计,以研究CDP-SOT的重测可靠性以及该测试区分残疾程度较低与较高参与者的能力。自我报告的残疾水平基于患者确定的疾病阶段(PDDS)量表评分:较低(PDDS量表评分,0 - 3;n = 17)和较高(PDDS量表评分,4 - 6;n = 13)。
CDP-SOT的所有六种测试条件均具有良好至极佳的可靠性(组内相关系数,0.70 - 0.90),综合评分的可靠性极佳(0.90)。在第1次测试时,残疾程度较低组的综合评分显著高于残疾程度较高组(70.89对48.60,P = .001),第2次测试时也是如此(74.82对48.85,P = .002)。
CDP-SOT是一种可靠的平衡测量方法,能够准确区分MS患者的残疾状态。总体而言,这些结果支持将CDP-SOT作为一种可靠且有效的测量方法应用于临床,以评估与感觉整合相关的平衡受损的疾病相关进展,及其在确定平衡对治疗反应变化方面的效用。